Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Microbiol Spectr. 2016 Dec;4(6):10.1128/microbiolspec.TBTB2-0025-2016. doi: 10.1128/microbiolspec.TBTB2-0025-2016

Figure 3. Flow sorting of activated and resting M. tuberculosis-infected host cells demonstrates that the drug sensitivity of M. tuberculosis recovered from in vivo infection correlates inversely with the immune activation status of the host phagocyte.

Figure 3

(A–C) M. tuberculosis recovered from activated host cells in vivo were more tolerant to both INH and RIF than those recovered from resting host cells. C57BL/6J mice were infected with mCherry-expressing M. tuberculosis Erdman for 21 days, and M. tuberculosis-containing myeloid cells with different immune activation status isolated from lung tissue using flow cytometry. (A) CD11b+ mCherry+ CD80high cells (activated population) and CD11b+ mCherry+ CD80low cells (resting population) were sorted according to the depicted gating strategies. (B–C) Isolated cells were established in culture and subjected to treatment with 1 µg/ml INH or RIF, or an equivalent volume of DMSO. Following 24 h drug treatment, bacterial survival was determined by CFU enumeration (B), and the percentage of M. tuberculosis surviving drug treatment quantified by normalizing bacterial load in drug-treated samples against that in DMSO-treated samples (C). This figure is modified from the work of Lui et al, (34).